Corvus Pharmaceuticals, Roche, Genentech deal

Corvus partnered with Roche’s Genentech unit to conduct a Phase I/Ib clinical trial of Corvus’ CPI-444 as a single agent and in combination with Genentech’s atezolizumab ( MPDL3280A, RG7446) to trea...